CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022		72,817,887
Beginning balance at Dec. 31, 2022	$ 145,700	$ 7	$ 561,390	$ (7,246)	$ (408,451)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(111,441)				(111,441)
Issuance of common stock to directors (in shares)		19,687
Vesting of restricted stock units (in shares)		430,582
Vesting of restricted stock units	$ (9,748)		(9,748)
Exercise of stock options (in shares)	98,610	98,610
Exercise of stock options	$ 752		752
Stock-based compensation expense	43,387		43,387
Other comprehensive income (loss)	(16,309)			(16,309)
Ending balance (in shares) at Dec. 31, 2023		73,366,766
Ending balance at Dec. 31, 2023	52,341	$ 7	595,781	(23,555)	(519,892)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(92,262)				(92,262)
Issuance of common stock to directors (in shares)		20,216
Issuance of common stock to directors	0		(369)			369
Vesting of restricted stock units (in shares)		418,899
Vesting of restricted stock units	$ (7,987)		(13,533)			5,546
Exercise of stock options (in shares)	1,543,436	1,543,436
Exercise of stock options	$ 14,461		(29,643)			44,104
Repurchase of common stock (in shares)		(1,320,531)
Repurchase of common stock	(50,019)					(50,019)
Stock-based compensation expense	39,045		39,045
Other comprehensive income (loss)	11,781			11,781
Ending balance (in shares) at Dec. 31, 2024		74,028,786
Ending balance at Dec. 31, 2024	(32,640)	$ 7	591,281	(11,774)	(612,154)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,233				1,233
Issuance of common stock to directors (in shares)		22,829
Vesting of restricted stock units (in shares)		434,940
Vesting of restricted stock units	$ (7,396)		(10,441)			3,045
Exercise of stock options (in shares)	107,821	107,821
Exercise of stock options	$ 1,118		1,098			20
Repurchase of common stock (in shares)		(639,751)
Repurchase of common stock						(20,000)
Stock-based compensation expense	35,380		35,380
Other comprehensive income (loss)	$ (24,688)			(24,688)
Ending balance (in shares) at Dec. 31, 2025	74,000,000	73,954,625
Ending balance at Dec. 31, 2025	$ (46,993)	$ 7	$ 617,318	$ (36,462)	$ (610,921)	$ (16,935)